Annual report pursuant to Section 13 and 15(d)

Stock Plans (Tables)

v3.22.4
Stock Plans (Tables)
12 Months Ended
Dec. 31, 2022
Schedule of Stock-based Compensation Expense

 

 

 

Year Ended
December 31,

 

 

 

2022

 

 

2021

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

Restricted stock units

 

$

13,044

 

 

$

19,088

 

Stock awards

 

 

 

 

 

19

 

Performance-based stock options

 

 

 

 

 

16,315

 

Stock options

 

 

5,304

 

 

 

3,720

 

Employee stock purchase plan

 

 

728

 

 

 

423

 

Common stock issued for services

 

 

39

 

 

 

500

 

Total stock-based compensation expense

 

$

19,115

 

 

$

40,065

 

 

 

 

 

 

 

 

Stock-based compensation expense by operating expense grouping:

 

 

 

 

 

 

Cost of revenue

 

$

116

 

 

$

116

 

Sales and marketing

 

 

2,263

 

 

 

1,716

 

Research and development

 

 

5,056

 

 

 

3,217

 

General and administrative

 

 

11,680

 

 

 

35,016

 

Total stock-based compensation expense

 

 

19,115

 

 

 

40,065

 

 

S
Schedule of Restricted Stock Unit Activity

The Company’s restricted stock unit activity for the year ended December 31, 2022 was as follows:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average Grant

 

 

 

Shares

 

 

Date Fair Value

 

Unvested at December 31, 2021

 

 

886,461

 

 

$

32.56

 

Granted

 

 

768,964

 

 

$

13.13

 

Forfeited

 

 

(67,444

)

 

$

24.86

 

Vested

 

 

(539,147

)

 

$

36.16

 

Unvested at December 31, 2022

 

 

1,048,834

 

 

$

15.28

 

Schedule of Stock Option Activity

The activity during the year ended December 31, 2022 related to all other stock options was as follows:

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2021

 

 

5,508,608

 

 

$

15.10

 

 

 

 

 

 

Granted

 

 

721,717

 

 

$

11.01

 

 

 

 

 

 

Exercised

 

 

(68,761

)

 

$

5.35

 

 

 

 

 

 

Forfeited

 

 

(228,065

)

 

$

19.58

 

 

 

 

 

 

Expired

 

 

(65,714

)

 

$

15.31

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

5,867,785

 

 

$

14.53

 

 

5.76 years

 

$

1,270

 

Exercisable at December 31, 2022

 

 

4,604,406

 

 

$

14.18

 

 

4.88 years

 

$

977

 

Employee Stock Purchase Plan [Member]  
Summary of Fair Value Assumptions of Stock Purchase Plan

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the years ended December 31, 2022 and 2021 are set forth in the table below:

 

 

 

Year ended
December 31, 2022

 

 

Year Ended
December 31, 2021

 

Expected term (in years)

 

0.5 - 2.0

 

 

0.5 - 2.0

 

Expected volatility

 

67% - 119%

 

 

67% - 119%

 

Risk-free interest rate

 

0.1% - 3.0%

 

 

0.1%

 

Expected dividend yield

 

 

 

 

 

 

Stock Options [Member]  
Schedule of Fair Value Assumptions The following assumptions were used to compute the grant date fair values of the stock options granted during the years ended December 31, 2022 and 2021:

 

 

 

Year ended
December 31, 2022

 

 

Year Ended
December 31, 2021

 

Expected term (in years)

 

5.5 - 6.8

 

 

5.5 - 6.1

 

Expected volatility

 

82% - 92%

 

 

80% - 83%

 

Risk-free interest rate

 

1.7% - 3.7%

 

 

0.6% - 1.4%

 

Expected dividend yield

 

 

 

 

 

 

Performance-based Stock Options [Member]  
Schedule of Stock Option Activity

The activity during the year ended December 31, 2022 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows:

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

Remaining

 

Aggregate

 

 

 

 

 

 

Exercise

 

 

Contractual

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

Term

 

Value

 

Outstanding at December 31, 2021

 

 

3,834,441

 

 

$

11.05

 

 

 

 

 

 

Exercised

 

 

(46,291

)

 

$

5.64

 

 

 

 

 

 

Expired

 

 

(25,471

)

 

$

5.46

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

3,762,679

 

 

$

11.15

 

 

5.51 years

 

$

1

 

Exercisable at December 31, 2022

 

 

3,762,679

 

 

$

11.15

 

 

5.51 years

 

$

1